J. Davagnino

发表

The carboxy-terminal portion of the CheA kinase mediates regulation of autophosphorylation by transducer and CheW

M. Simon, Melvin I. Simon, R. Bourret, 1993, Journal of bacteriology.

The DNA replication inhibitor microcin B17 is a forty‐three‐amino‐acid protein containing sixty percent glycine

R. Kolter, J. Davagnino, D. Furlong, 1986, Proteins.

Particulate methane monooxygenase genes in methanotrophs

M. Lidstrom, J. Davagnino, A. Holmes, 1995, Journal of bacteriology.

The identification of extrahepatic "glucokinase" as N-acetylglucosamine kinase.

J. Davagnino, T. Ureta, 1980, The Journal of biological chemistry.

Caffeine as a Viscosity Reducer for Highly Concentrated Monoclonal Antibody Solutions.

D. Soane, J. Davagnino, Daniel G. Greene, 2021, Journal of pharmaceutical sciences.

The maturation pathway of microcin B17, a peptide inhibitor of DNA gyrase

R. Kolter, J. Davagnino, R Kolter, 1993, Molecular microbiology.

An RNA polymerase preparation from Methylobacterium extorquens AM1 capable of transcribing from a methylotrophic promoter.

M. Lidstrom, J. Davagnino, A. Springer, 1998, Microbiology.

Mapping of solution components, pH changes, protein stability and the elimination of protein precipitation during freeze-thawing of fibroblast growth factor 20.

J. Davagnino, C. Karkaria, Haripada Maity, 2009, International journal of pharmaceutics.

Acid hydrolysis of monoclonal antibodies.

J. Davagnino, S. Mankarious, C. Wong, 1995, Journal of immunological methods.

Lyophilized Drug Product Cake Appearance: What Is Acceptable?

Gerhard Winter, Andrea Hawe, Steven L Nail, 2017, Journal of pharmaceutical sciences.

autophosphorylation by transducer and CheW. kinase mediates regulation of The carboxy-terminal portion of the CheA

M. Simon, R. Bourret, J. Davagnino, 2013 .

Effects of pH and arginine on the solubility and stability of a therapeutic protein (Fibroblast Growth Factor 20): relationship between solubility and stability.

J. Davagnino, C. Karkaria, Haripada Maity, 2009, Current pharmaceutical biotechnology.

Developing Lyophilized Formulations for Protein Biopharmaceuticals Containing Salt that Produce Placebos of Corresponding Appearance.

John P. Gabrielson, J. Davagnino, 2022, Journal of pharmaceutical sciences.